Oryzon Genomics S.A. (LON:0RDB)
London · Delayed Price · Currency is GBP · Price in EUR 3.115
-0.015 (-0.48%)
Feb 12, 2026, 11:33 AM GMT
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of 210.54 million as of February 12, 2026. Its market cap has increased by 174.24% in one year.
Market Cap
210.54M
Enterprise Value
199.22M
Revenue
6.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.12
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 88.97M to 210.54M, an increase of 136.63%. That is a compound annual growth rate of 8.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 213.26M | -0.31% |
| Dec 31, 2025 | 213.93M | 185.55% |
| Dec 31, 2024 | 74.92M | -20.63% |
| Dec 29, 2023 | 94.39M | -20.04% |
| Dec 30, 2022 | 118.04M | -1.22% |
| Dec 30, 2021 | 119.51M | -36.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 11.10B |
| NIOX Group | 272.49M |
| Avacta Group | 260.26M |
| Integrated Diagnostics Holdings | 259.90M |
| Tristel | 203.19M |